Skip to main content

Evofem Biosciences, Inc.

corporate_fare Company Profile

Evofem Biosciences, Inc.

EVFM·OTC·Life Sciences·CIK 0001618835

We are a San Diego-based commercial-stage biopharmaceutical company focused on commercializing products for women's sexual and reproductive health. Our first commercial product, PHEXX®, was approved by the FDA on May 22, 2020, for pregnancy prevention and launched in the U.S. in September 2020. PHEXX is a non-hormonal prescription contraceptive vaginal gel, used 0-60 minutes before intercourse. It is hormone-free and non-systemic, avoiding side effects associated with hormonal methods such as depression, weight gain, headaches, loss of libido, mood swings, and irritability. Hormonal contraceptives may not be suitable for women with certain medical conditions, including clotting disorders, hormone-sensitive cancers, diabetes, or a BMI over 30, as well as those who are breastfeeding or smoke. According to the National Center for Health Statistics, approximately 15.9 million women in the U.S. do not wish to become pregnant and will not use a hormonal contraceptive, based on 2022-2023 data. We acquired global rights to SOLOSEC® on July 14, 2024, and relaunched it in November 2024. SOLOSEC is an FDA-approved single-dose oral antimicrobial for treating bacterial vaginosis (BV) and trichomoniasis. Outside the U.S., we commercialize our products through partnerships and/or license agreements.

Evofem Biosciences, Inc. (OTC:EVFM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 15 items for EVFM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 10/10, with 11 rated 8 or above. Recent SEC coverage for EVFM spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • Evofem Executes 1-for-1,500 Reverse Split, Cutting Shares From 132.5M to ~88,353
  • Evofem Q3 2026: $1.0M Quarterly Profit Masks Going-Concern Warning and Dec 1 Debt Wall
  • Evofem Amends Adjuvant Notes: Full Repayment Due December 1, 2026
  • Evofem Adds Second Phexx Manufacturing Source, Cutting Unit Costs 40%+
  • Evofem Biosciences Reports $16.5M Loss, Warns of Going Concern Doubt

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$20.18M
Net Income
$391K
Diluted EPS
$0.00
Op. Cash Flow
-$1.99M
Free Cash Flow
-$2M
Gross Profit
$15.57M
Operating Income
$3.37M
Cash & Equivalents
$578K
Total Debt
$147K
Debt / Equity
-0.00×
Net Margin
1.9%
Shares Outstanding
126.69M sh
Source: 10-K · filed 2026-03-11 · accession 0001493152-26-009686

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 11,365 shares in EVFM as of the October 30, 2026 settlement, a 134.6% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 17, 2026, 70.9% of EVFM volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)11,365 shares as of October 30, 2026
Change vs prior period▲ 134.6%
Days to cover1.00 at avg daily volume of 109,911
Daily short volume (FINRA facilities)70.9% of 2,695,018 shares on November 17, 2026
3-day average short volume63.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with E →
$0.0043
Market cap
$569.88K
Volume
2.7M (12.3× avg)
3-mo avg 219.7K
Last traded · 2026-11-18

show_chartPrice Chart

Loading chart...

feed EVFM - Latest Insights

EVFM
Nov 18, 2026, 4:58 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0043
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Nov 13, 2026, 4:57 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0062
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Oct 15, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0070
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Sep 23, 2026, 5:08 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.0077
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Aug 14, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.007524
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Jul 14, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.0083
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Jul 14, 2026, 4:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0083
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
May 15, 2026, 5:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.0067
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
May 15, 2026, 5:05 PM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $0.0067
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Apr 30, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.0065
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Apr 16, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0089
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Mar 19, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0085
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Mar 11, 2026, 6:34 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.0087
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Mar 11, 2026, 4:43 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.0087
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
EVFM
Jan 12, 2026, 5:01 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0091
Real-time Price: $0.0043 info
Change: Reverse Stock Split info
Market Cap: $569.879K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets